Enanta Pharmaceuticals
ENTA
#8607
Rank
NZ$0.25 B
Marketcap
$11.96
Share price
-6.05%
Change (1 day)
-48.92%
Change (1 year)

P/S ratio for Enanta Pharmaceuticals (ENTA)

P/S ratio as of March 2025 (TTM): 2.19

According to Enanta Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.30. At the end of 2024 the company had a P/S ratio of 1.91.

P/S ratio history for Enanta Pharmaceuticals from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.91-28.93%
20232.69-77.16%
202211.8-28.54%
202116.598.3%
20208.3227.67%
20196.5112.81%
20185.77-32.86%
20178.60-32.26%
201612.7169.68%
20154.71-38.15%
20147.61-92.1%
201396.3

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
6.63 202.99%๐Ÿ‡บ๐Ÿ‡ธ USA
4.42 102.11%๐Ÿ‡บ๐Ÿ‡ธ USA
11.7 435.60%๐Ÿ‡บ๐Ÿ‡ธ USA
3.79 73.08%๐Ÿ‡บ๐Ÿ‡ธ USA
2.53 15.75%๐Ÿ‡บ๐Ÿ‡ธ USA
4.20 91.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland